Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The Early Endosome: Endocytosis of Transferrin01:28

The Early Endosome: Endocytosis of Transferrin

3.3K
Essential proteins such as insulin or low-density lipoprotein (LDL) and micronutrients such as iron enter a eukaryotic cell through receptor-mediated endocytosis. Subsequently, the early endosomes fuse with the vesicles containing such receptor-ligand complexes and play a vital role in sorting the incoming ligands and receptors. While the ligands are either degraded inside the vesicle or released into the cytosol, their receptors are returned to the plasma membrane for further rounds of...
3.3K
Subcellular Fractionation01:32

Subcellular Fractionation

7.0K
The homogenate obtained after cell lysis contains various membrane-bound organelles that can be further separated into pure fractions by subcellular fractionation. These isolates are used to study specific cellular components, analyze localized protein activity, and are even employed in diagnostics. Fractionation is typically achieved using centrifugation methods, the most common being density-gradient and differential centrifugation.
Differential Centrifugation
Differential centrifugation is...
7.0K
Extraction: Advanced Methods00:56

Extraction: Advanced Methods

446
Metal ions can be separated from one another by complexation with organic ligands–the chelating agent– to form uncharged chelates. Here, the chelating agent must contain hydrophobic groups and behave as a weak acid, losing a proton to bind with the metal. Since most organic ligands used in this process are insoluble or undergo oxidation in the aqueous phase, the chelating agent is initially added to the organic phase and extracted into the aqueous phase. The metal-ligand complex is...
446
The Periodic Table and Organismal Elements00:57

The Periodic Table and Organismal Elements

178.2K
Overview
178.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Synergistic mode-field pre-expansion and geometric compression in hetero-structured microfibers for ultrasensitive glucose sensing.

Biosensors & bioelectronics·2026
Same author

A Dual-Domain Multiplexed QEPAS System for Multispecies Gas Detection Based on Wavelength-Selective LPFG.

Analytical chemistry·2026
Same author

Corrigendum to "Apolipophorin-III inhibits BmNPV replication by reprogramming sphingolipid metabolism to accumulate ceramide" [J. Invertebr. Pathol. 217 (2026) 108622].

Journal of invertebrate pathology·2026
Same author

Circadian rhythm disruption affects cellular senescence through the BMAL1/CRY2/PER1 signaling pathway in periodontitis.

Journal of molecular histology·2026
Same author

Self-adjuvanting α-helical polypeptide simultaneously delivers neoantigen mRNAs and activates dendritic cells to eradicate tumors.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Apolipophorin-III inhibits BmNPV replication by reprogramming sphingolipid metabolism to accumulate ceramide.

Journal of invertebrate pathology·2026

Related Experiment Video

Updated: Jun 27, 2025

Quantitating Iron Transport Across the Mouse Placenta In Vivo Using Nonradioactive Iron Isotopes
08:45

Quantitating Iron Transport Across the Mouse Placenta In Vivo Using Nonradioactive Iron Isotopes

Published on: May 10, 2022

2.0K

Minimizing higher-order aggregation maximizes iron mobilization by small molecules.

Andrew D Blake1, Jianhua Chao2, Anna M SantaMaria1

  • 1Department of Biochemistry, University of Illinois at Urbana-Champaign, Urbana, IL, USA.

Nature Chemical Biology
|April 25, 2024
PubMed
Summary
This summary is machine-generated.

Scientists developed FeM-1269, a novel iron-mobilizing molecule. It effectively transports iron across cell membranes at high concentrations, unlike hinokitiol, offering potential for treating iron deficiency disorders.

More Related Videos

Author Spotlight: Assessing the Impact of Novel Iron Chelators on Cancer Cell Metabolism
05:36

Author Spotlight: Assessing the Impact of Novel Iron Chelators on Cancer Cell Metabolism

Published on: February 23, 2024

471
Setup of Capillary Electrophoresis-Inductively Coupled Plasma Mass Spectrometry CE-ICP-MS for Quantification of Iron Redox Species FeII, FeIII
04:48

Setup of Capillary Electrophoresis-Inductively Coupled Plasma Mass Spectrometry CE-ICP-MS for Quantification of Iron Redox Species FeII, FeIII

Published on: May 4, 2020

8.1K

Related Experiment Videos

Last Updated: Jun 27, 2025

Quantitating Iron Transport Across the Mouse Placenta In Vivo Using Nonradioactive Iron Isotopes
08:45

Quantitating Iron Transport Across the Mouse Placenta In Vivo Using Nonradioactive Iron Isotopes

Published on: May 10, 2022

2.0K
Author Spotlight: Assessing the Impact of Novel Iron Chelators on Cancer Cell Metabolism
05:36

Author Spotlight: Assessing the Impact of Novel Iron Chelators on Cancer Cell Metabolism

Published on: February 23, 2024

471
Setup of Capillary Electrophoresis-Inductively Coupled Plasma Mass Spectrometry CE-ICP-MS for Quantification of Iron Redox Species FeII, FeIII
04:48

Setup of Capillary Electrophoresis-Inductively Coupled Plasma Mass Spectrometry CE-ICP-MS for Quantification of Iron Redox Species FeII, FeIII

Published on: May 4, 2020

8.1K

Area of Science:

  • Biochemistry
  • Medicinal Chemistry
  • Molecular Biology

Background:

  • Hinokitiol mobilizes iron across lipid bilayers but aggregates at higher concentrations, limiting its therapeutic potential.
  • Iron transporter deficiencies can lead to various health issues, necessitating effective iron-mobilizing agents.

Purpose of the Study:

  • To understand the aggregation behavior of hinokitiol-iron complexes at higher concentrations.
  • To develop a novel, stable iron-mobilizing small molecule with enhanced therapeutic potential.

Main Methods:

  • Investigated the aggregation of hinokitiol-Fe(III) complexes using structural studies.
  • Conducted systematic structure-function analyses with modular synthesis to identify new compounds.
  • Evaluated the efficacy and safety of the developed compound (FeM-1269) in vitro and in an animal model.

Main Results:

  • Hinokitiol forms higher-order aggregates with Fe(III) at high concentrations, impairing iron mobilization.
  • FeM-1269 demonstrates dose-dependent iron mobilization across lipid bilayers with minimal aggregation, even at high concentrations.
  • FeM-1269 is well-tolerated in animals and effectively improves iron levels and red blood cell parameters in a mouse model of anemia.

Conclusions:

  • FeM-1269 overcomes the limitations of hinokitiol by remaining soluble and active at high concentrations.
  • This rationally designed molecule shows promise as a molecular prosthetic for understanding and treating iron transporter deficiencies and related anemias.